Skip to content

Clinical trials

Recruiting Inflammation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Status: Recruiting Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20222
20233
20245
202510
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital3
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2
Capital Medical University1
Central South University1
China National Center for Cardiovascular Diseases1
Chongqing Medical University1
General Hospital of Shenyang Military Region1
Guangzhou Institute of Respiratory Disease1
Huashan Hospital1
Hubei Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation23
Coronary Artery Disease5
Coronary Restenosis3
Coronary Stenosis3
Disease Progression3
Liver Cirrhosis2
Amyotrophic Lateral Sclerosis1
Aortic Dissection1
Arteritis1
Atherosclerosis1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.